{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:33:16Z","timestamp":1760887996985},"reference-count":33,"publisher":"Frontline Medical Communications, Inc.","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1053\/sder.2001.29060","type":"journal-article","created":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T19:17:37Z","timestamp":1168370257000},"page":"268-274","source":"Crossref","is-referenced-by-count":17,"title":["Topical tacrolimus and pimecrolimus: Future directions"],"prefix":"10.12788","volume":"20","author":[{"given":"Mark R.","family":"Ling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5043","reference":[{"key":"10.1053\/sder.2001.29060_bib1","series-title":"Abstract. Soc Invest Dermatol Annual Meeting","article-title":"Tacrolimus 0.1% ointment in the treatment of eyelid dermatitis","author":"Krupnick","year":"2001"},{"key":"10.1053\/sder.2001.29060_bib2","first-page":"262","article-title":"The role of Pityrosporum ovale in seborrheic dermatitis","volume":"9","author":"Bergbrant","year":"1990","journal-title":"Semin Dermatol"},{"key":"10.1053\/sder.2001.29060_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00044011-199612050-00003","article-title":"Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis","volume":"12","author":"Nakagawa","year":"1996","journal-title":"Clin Drug Invest"},{"key":"10.1053\/sder.2001.29060_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00402225","article-title":"Topical FK506: Suppression of allergic and irritant contact dermatitis in the guinea pig","volume":"286","author":"Lauerma","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1053\/sder.2001.29060_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-2999(97)00116-7","article-title":"A local lymph node assay to analyse immunosuppressive effects of topically applied drugs","volume":"325","author":"Homey","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1053\/sder.2001.29060_bib6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/1523-1747.ep12456939","article-title":"Immunosuppressive macrolides of the type FK506: A novel class of topical agents for treatment of skin diseases?","volume":"98","author":"Meingassner","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1053\/sder.2001.29060_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0140-6736(92)91757-Y","article-title":"Inhibition of contact allergy reactions by topical FK506","volume":"340","author":"Lauerma","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/sder.2001.29060_bib8","first-page":"747","article-title":"Significant absorption of topical taclolimus in 3 patients with Netherton Syndrome","volume":"137","author":"Allen","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.29060_bib9","series-title":"Poster presented at the 58th Annual Meeting of the American Academy of Dermatology","article-title":"A long-term noncomparative trial to evaluate the safety of topically applied tacrolimus as treatment of atopic dermatitis in pediatric patients","author":"Kang","year":"2000"},{"key":"10.1053\/sder.2001.29060_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.1992.01680160065005","article-title":"Tacrolimus (FK506): A new therapeutic agent for severe recalcitrant psoriasis","volume":"128","author":"Jegasothy","year":"1992","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.29060_bib11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/archderm.1996.03890280081011","article-title":"Systemic tacrolimus is effective for the treatment of psoriasis in a double-blind, placebo-controlled study","volume":"132","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.29060_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0955-470X(95)80026-5","article-title":"Comparative evaluation of tacrolimus (FK506) and cyclosporin A as immunosuppressive agents","volume":"9","author":"Manez","year":"1995","journal-title":"Transpl Rev"},{"key":"10.1053\/sder.2001.29060_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2340\/0001555572321326","article-title":"The enigma of cyclosporin A treatment for psoriasis: Systemic efficacy versus topical nonresponsiveness","volume":"72","author":"Mrowietz","year":"1992","journal-title":"A review Acta Derm Venereol"},{"key":"10.1053\/sder.2001.29060_bib14","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archderm.134.9.1101","article-title":"Topical tacrolimus is not effective in chronic plaque psoriasis: A pilot study","volume":"134","author":"Zonneveld","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.29060_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2133.1999.02927.x","article-title":"Tacrolimus ointment improves psoriasis in a microplaque assay","volume":"141","author":"Remitz","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib16","series-title":"Abstract presented at 59th Annual Meeting of the American Academy of Dermatology","article-title":"Oral SDZ ASM 981: Clinical safety, tolerability, and efficacy in patients with moderate to severe chronic plaque psoriasis","author":"Greig","year":"2001"},{"key":"10.1053\/sder.2001.29060_bib17","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.1998.02554.x","article-title":"The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion","volume":"139","author":"Mrowietz","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib18","first-page":"44","article-title":"An insider's guide to new psoriasis treatments","volume":"9","author":"Lebwohl","year":"2001","journal-title":"Skin & Aging"},{"key":"10.1053\/sder.2001.29060_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2133.1997.tb03777.x","article-title":"Topical FK506: A potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model","volume":"137","author":"McElwee","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/1523-1747.ep12371755","article-title":"Stimulation of hair growth by topical application of FK506, a potent immunosuppressive agent","volume":"102","author":"Yamamoto","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1053\/sder.2001.29060_bib21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: Treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.29060_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2133.1999.02672.x","article-title":"Erosive mucosal lichen planus: Response to topical treatment with tacrolimus","volume":"140","author":"Vente","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib23","first-page":"419","article-title":"Successful treatment of erosive lichen planus with topical tacrolimus","volume":"137","author":"Lener","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1053\/sder.2001.29060_bib24","unstructured":"Choi CJ, Nghiem P: Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease: A case series of 18 patients. Abstract. Society of Investigative Dermatology Annual Meeting"},{"issue":"suppl 1","key":"10.1053\/sder.2001.29060_bib25","first-page":"370b","article-title":"Topical tacrolimus may be useful on skin manifestations of acute and chronic graft-versus-host disease (GVHD) after bone marrow transplantation (BMT)","volume":"94","author":"Narwani","year":"1999","journal-title":"Blood"},{"key":"10.1053\/sder.2001.29060_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2133.1999.02745.x","article-title":"Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus","volume":"140","author":"Lyon","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2133.1999.02746.x","article-title":"Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum","volume":"140","author":"Jolles","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib28","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/S0140-6736(05)78962-5","article-title":"Topical tacrolimus for pyoderma gangrenosum","volume":"351","author":"Schuppe","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/sder.2001.29060_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1365-2133.1998.02491.x","article-title":"Topical tacrolimus for pyoderma gangrenosum","volume":"139","author":"Reich","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1053\/sder.2001.29060_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/rheumatology\/39.1.105","article-title":"Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis","volume":"39","author":"Schuppe","year":"2000","journal-title":"Rheumatology"},{"key":"10.1053\/sder.2001.29060_bib31","first-page":"436","article-title":"Topical tacrolimus may be effective in the treatment of oral and perincal","volume":"47","author":"Casson","year":"2000","journal-title":"Crohn's disease. Gut"},{"key":"10.1053\/sder.2001.29060_bib32","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mjd.2001.114739","article-title":"Tacrolimus ointment for the treatment of steroid-induced rosacea: A preliminary report","volume":"44","author":"Goldman","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/sder.2001.29060_bib33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(05)73849-6","article-title":"Eosinophilic pustular folliculitis","volume":"356","author":"Dale","year":"2000","journal-title":"Lancet"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562901800171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562901800171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/08\/v20i4-Ling.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:52Z","timestamp":1707524092000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1085562901800171"],"URL":"https:\/\/doi.org\/10.1053\/sder.2001.29060","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}